According to research reviewed by Gram, an early anti-inflammatory diet eaten by mouth appears safe for people with mild acute pancreatitis, a painful swelling of the pancreas. In a 2026 randomized trial of 68 patients, the diet group had lower C-reactive protein, a marker of inflammation, and a lower 30-day readmission rate.
A new randomized trial, reviewed in a Gram Research analysis, tested whether an anti-inflammatory diet started by mouth early in the hospital stay could help people with mild acute pancreatitis, a painful swelling of the pancreas. The 68 patients were split into two groups. One group ate the anti-inflammatory diet, and the other followed standard hospital diet care. The diet group had lower levels of C-reactive protein, a blood marker of inflammation, and fewer loose stools. They also had a lower 30-day readmission rate and healthier gut bacteria patterns. Blood tests for pancreas strain showed no meaningful differences between groups, which suggests the diet was safe. The study was small and done at one hospital, so larger studies are needed before this becomes standard care.
Key Statistics
A 2026 randomized controlled trial of 68 patients with mild acute pancreatitis found that an early anti-inflammatory diet was associated with a significantly lower 30-day readmission rate than standard hospital diet care (P = 0.039).
In the same 2026 trial, patients who followed the anti-inflammatory diet had significantly lower levels of high-sensitivity C-reactive protein, a blood marker of inflammation, than the standard care group (P = 0.013).
The 2026 study also reported significantly fewer cases of loose stools in the anti-inflammatory diet group (P = 0.007), with no significant differences in pancreas enzyme levels between groups.
The Quick Take
- What they studied: Can a special anti-inflammatory diet, started by mouth early in the hospital, be safe and helpful for people with mild acute pancreatitis?
- Who participated: 68 adults hospitalized with mild acute pancreatitis at one hospital in Mianyang, Sichuan Province, China, between December 2024 and December 2025. Half were randomly placed in the diet group and half in the standard care group, with 34 people in each.
- Key finding: People on the anti-inflammatory diet had lower levels of C-reactive protein, a marker of inflammation, and fewer cases of loose stools. Their 30-day readmission rate was also lower (P = 0.039), meaning the difference was unlikely to be due to chance alone.
- What it means for you: If you are recovering from mild pancreatitis, this early research suggests a carefully planned anti-inflammatory diet may be safe and may help. Always follow your own doctor’s or dietitian’s instructions, since this is one small study from one hospital.
The Research Details
This was a randomized controlled trial, which is one of the most reliable ways to test whether a treatment works. Researchers randomly assigned each patient, by chance, to one of two groups. This random assignment helps make the two groups similar at the start, so any differences found later are more likely caused by the diet itself.
The control group received the hospital’s usual diet plan for pancreatitis. The intervention group followed a newly designed anti-inflammatory diet, which focused on foods thought to calm inflammation in the body and support healthy gut bacteria. Patients were tracked over time, with blood samples, body weight measurements, stool samples, and records of symptoms and hospital readmissions.
Researchers used statistical methods designed for repeated measurements over time, which fits this kind of study because the same patients were checked several times. They looked at safety measures, such as pancreas enzyme levels and digestive symptoms, alongside measures of how well the diet worked, such as inflammation markers and nutrition status.
A randomized design is important because it reduces the chance that other factors, like age or illness severity, explain the results. Tracking patients over time also shows whether benefits and side effects change during recovery, not just at one point.
Because the study measured both safety and benefits in the same trial, readers can see the trade-offs. For example, the diet appeared safe for the pancreas, but the study still had to confirm that patients could eat it without new problems.
Strengths include random assignment, a pre-registered trial (Chinese Clinical Trial Registry ChiCTR2400094056), and clear measures of safety and effectiveness. Both groups were similar in size, with 34 patients each.
There are important limits to keep in mind. The trial was small, included only one hospital, and ran for a single year. Some reported results, such as shorter hospital stays, are described in the summary of the research but were not clearly shown in the results available here. Findings from a small, single-center trial are promising but not conclusive.
What the Results Show
The main question was whether the anti-inflammatory diet was safe. Researchers found no significant difference between groups in abdominal pain or bloating. Levels of lipase and amylase, two enzymes that rise when the pancreas is inflamed, and triglycerides, a blood fat, were also similar in both groups. This suggests the diet did not strain the pancreas or raise fat levels in the blood.
One safety result stood out. The diet group had significantly fewer cases of loose stools (P = 0.007). This suggests the diet may be gentler on digestion than the usual approach for some patients, though the study was not designed to explain why.
For benefits, the diet group showed lower levels of high-sensitivity C-reactive protein (P = 0.013), a blood marker that rises during inflammation. Their blood sugar two hours after eating was also lower (P = 0.045). Lower inflammation and steadier blood sugar are both signs that the body was handling the illness more effectively.
The diet group also had smaller drops in albumin, prealbumin, and body weight. Albumin and prealbumin are proteins that reflect nutritional reserves, so a smaller drop suggests the diet helped protect the body’s nutrition during illness. The 30-day readmission rate was also significantly lower in the diet group (P = 0.039), which is one of the most practical results for patients.
The researchers also examined the gut microbiome, the community of bacteria living in the digestive tract. The diet group had higher levels of beneficial bacteria, including Veillonella and Bifidobacterium. The control group showed higher levels of Corynebacteriaceae, a bacterial family that was less favorable in this study.
These gut bacteria changes are interesting because gut health is linked to inflammation and recovery. However, the study did not prove that these bacteria caused better outcomes. They show an association, which means the changes happened alongside the diet and may or may not be the main reason for the benefits.
The authors also described the diet as reducing the economic burden on patients, mainly through fewer readmissions and possibly shorter hospital stays. These points are useful for hospital planning, but the cost and length-of-stay details need to be confirmed in larger studies.
Researchers have long known that early eating, rather than waiting many days with no food, can help people with mild pancreatitis recover. Previous work has also shown that anti-inflammatory eating patterns can lower inflammation and affect gut bacteria in other conditions. This study moves that idea into the hospital setting for mild pancreatitis, where specific diet guidance has been limited.
The finding that early oral eating did not worsen pancreas enzymes or fats fits with earlier research showing that starting food by mouth early is generally safe for mild cases. This trial adds a specific, structured diet plan rather than general advice to eat.
The trial included 68 patients from one hospital in one region of China, so the results may not apply to people elsewhere, with different diets, or with more severe illness. The study ran for one year, so it does not show whether benefits last for months or years after discharge.
The diet was compared with usual hospital care, not with other specific diets, so it is unclear whether another eating plan would work as well or better. Patients and staff could likely tell which diet they were following, which can influence how people report symptoms.
Some results were reported only briefly, and a few statistical details in the research summary are unclear. The findings should be treated as early evidence that needs confirmation in larger, multi-center trials.
The Bottom Line
Early evidence suggests that a carefully designed anti-inflammatory diet, started by mouth early in the hospital, may be a safe option for people with mild acute pancreatitis. Confidence is moderate: the randomized design is a strength, but the trial was small and came from a single hospital. Patients should follow a plan set by their medical team rather than adopting this diet on their own.
Hospital doctors, dietitians, and nurses who manage pancreatitis patients may find this useful when planning early nutrition. Patients recovering from mild pancreatitis, and their families, may want to ask their care team whether an anti-inflammatory diet is appropriate for them.
People with severe pancreatitis, those who are pregnant, people with kidney or liver disease, and anyone with other medical conditions should not change their diet based on this study without medical guidance. Those with a history of gallstones or alcohol-related pancreatitis should also consult their doctor first.
In this trial, differences in inflammation markers, digestive symptoms, and readmissions were measured during and shortly after the hospital stay, which is where the most visible changes appear. Changes in nutrition markers and gut bacteria may take longer to show and to settle. Readers should not expect a quick fix. Recovery from pancreatitis depends heavily on the cause and severity of the illness, and diet works alongside medical care rather than replacing it.
Frequently Asked Questions
Is an anti-inflammatory diet safe for mild acute pancreatitis?
A 2026 randomized trial of 68 patients found no significant differences in pancreas enzymes, abdominal pain, or bloating between groups. Patients on the anti-inflammatory diet had fewer loose stools. Researchers describe it as safe, though the study was small and conducted at one hospital.
Can an anti-inflammatory diet reduce hospital readmissions for pancreatitis?
In a 2026 randomized trial, the 30-day readmission rate was significantly lower among patients who followed an early anti-inflammatory diet (P = 0.039). Larger, multi-center studies are needed to confirm this effect before it becomes standard guidance.
Does eating early after pancreatitis help recovery?
Research reviewed by Gram suggests that starting food by mouth early can be safe for mild pancreatitis. A 2026 trial showed that a structured anti-inflammatory diet lowered inflammation markers and improved blood sugar after meals compared with standard hospital diet care.
How does diet affect gut bacteria during pancreatitis?
A 2026 study found that patients on an anti-inflammatory diet had higher levels of beneficial bacteria, including Veillonella and Bifidobacterium. These changes were associated with the diet, but the study did not prove that they directly caused better recovery.
Want to Apply This Research?
- Log daily stool consistency (using a simple 1 to 5 scale), abdominal comfort (0 to 10), and body weight each morning. Note any meals and whether they were followed by bloating or pain. Share these numbers with your care team at follow-up visits.
- Follow the eating plan your care team gives you, and pay attention to how each meal affects your digestion. Prefer simple, minimally processed foods, stay hydrated, and avoid alcohol. Use the app to flag any meal that causes symptoms so you can review it with your dietitian.
- Track weekly averages for weight, digestive comfort, and meal patterns over the first month after discharge. Log any missed doses of prescribed medications, new symptoms, or unplanned clinic or emergency visits. Review trends with your doctor, since changes in weight or symptoms can signal that a plan needs adjusting.
This article summarizes a single, small randomized trial of 68 patients at one hospital and is for general information only. It is not medical advice. Pancreatitis can be serious, and diet changes should only be made under the guidance of your doctor or a registered dietitian. Seek urgent medical care for severe abdominal pain, fever, vomiting, or yellowing of the skin or eyes.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.